IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: Asia/Pacific

DSM to Participate in Biopharmaceutical Project in Australia

8:22 AM MDT | May 14, 2010 | DEEPTI RAMESH

DSM Biologics, a DSM subsidiary, says it has signed preliminary agreements to enter into a partnership with state and local authorities in Australia to build and operate a mammalian biopharmaceutical manufacturing facility at Brisbane. The facility will be the first major mammalian contract manufacturing organization in Australia, DSM says. The Queensland and Australian governments will provide full financial funding for the facility, which forms part of a 10-year strategic biotechnology plan. DSM will provide no capital but it will supply technological expertise...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa